Quarterly report pursuant to sections 13 or 15(d)

Stock-Based Compensation (Tables)

v2.4.0.8
Stock-Based Compensation (Tables)
 3 Months Ended
Sep. 30, 2013
Share-Based Compensation [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock option activity is as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Options
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2012
 
-
 
$
-
 
-
 
Granted
 
9,050,000
 
$
0.75
 
 
 
Outstanding, June 30, 2013
 
9,050,000
 
$
0.75
 
4.6
 
Outstanding, September 30, 2013
 
9,050,000
 
$
0.75
 
4.3
 
 
 
 
 
 
 
 
 
 
Exercisable at September 30, 2013
 
6,490,974
 
$
0.75
 
4.3
 
Schedule Of Warrants Issued To Agents Activity [Table Text Block]
AntriaBio issued warrants to agents in conjunction with the closing of its convertible notes payable as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Warrants
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2012
 
-
 
$
-
 
-
 
Warrants issued to placement agents
 
248,542
 
$
0.33
 
 
 
Warrants issued to placement agent
 
1,400,000
 
$
-
 
 
 
Warrants issued to placement agent
 
110,000
 
$
0.85
 
 
 
Outstanding, June 30, 2013
 
1,758,542
 
$
0.31
 
4.1
 
Outstanding, September 30, 2013
 
1,758,542
 
$
0.31
 
3.9
 
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
Significant assumptions were as follows:
 
Expected volatility
 
100% - 111
%
 
Risk free interest rate
 
0.88% - 1.41
%
 
Expected term (years)
 
3.9 - 5
 
 
Dividend yield
 
0
%